NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
Ketamine, an NMDA blocker, was highly effective compared to active comparator in rapidly reducing Suicidality (p=0.0003)This study represents the second well-controlled trial NRx has licensed supporting the use of IV Ketamine in suicidal depression NRx plans to present the data from these two trials
Toastmasters 8 Tips for Keeping Your 2024 New Year’s Resolutions
ENGLEWOOD, Colo., Dec. 19, 2023 /PRNewswire/ — As 2024 approaches, many of our thoughts will turn to self-improvement and how we make the New Year as successful, satisfying, and productive as possible. Whether it’s improving our health, focusing on professional advancement, learning a ne
Vision Films to Release Female Led Sci-Fi Film ‘Crypto Shadows’ in the New Year
LOS ANGELES, Dec. 19, 2023 /PRNewswire/ — Vision Films Inc. (“Vision”) announces the North American Transactional VOD release of sci-fi thriller Crypto Shadows, from Cinemachine LLC and in association with Moving On Films, on January 16, 2024. Vision Films acquired the film in a de
Imagine Pharma Completes More Than 32 Clinical Human Islet Cell Isolation Procedures for Leading Hospital Systems in 2023
Partners with Cook MyoSite to establish a state-of-the-art facility to conduct human islet isolations for hospital systems without in-house capabilities PITTSBURGH, Dec. 19, 2023 /PRNewswire/ — Imagine Pharma, a biotech company focused on advancing the commercialization of its novel IMG-1 poly
New venture from industry veterans: BEYOND Hospitality launches with a mission to redefine sports hospitality
Founded by industry leaders, BEYOND Hospitality packs decades of industry innovation and expertise into their executive and leadership teams. ZURICH, Dec. 19, 2023 /PRNewswire/ — Hospitality industry innovator and executive chairman of Match Group Holdings Ltd, Jaime Byrom is excited to anno
SNP Therapeutics Launches Genate™: The First Gene-Guided Precision Nutrition Solution for the Prenatal Market
KANNAPOLIS, N.C., Dec. 19, 2023 /PRNewswire/ — SNP Therapeutics Inc announced today it is launching a line of prenatal nutrition products to complement its Genate™ Test, a prenatal genetic screening test. Genate Prenatal Nutrition will enable women to optimize their nutrition plan based on
Rosebud Communications Lands Lumotive: Becomes Semiconductor Company’s Global Agency of Record
LOS ANGELES, Dec. 19, 2023 /PRNewswire/ — Rosebud Communications, the fast-growing B2B PR and marketing agency for visionary tech firms, has marked another significant milestone by becoming the global agency of record for Lumotive, a semiconductor innovator disrupting the global 3D sensing mar
New Tweddle Group Website Features Thought-Leader Articles, Reflects Expanded Industry Offerings
The new tweddle.com connects organizations with crucial service tools and revolutionary “industry-agnostic” product information servicesNew blog area features SME think pieces on little-known best practicesUpdated content reflects Tweddle Group expansion into interactive learning, dia
Unicorn Hunters Introduces Healables, a Digital Health Company Developing AI-Powered Wearable Bioelectric Technology for Personalized Recovery, Performance and Pain Relief
The visionary founder of a digital health startup introduced a revolutionary wearable technology to the Circle of Money, presenting investors with an exclusive opportunity to invest in this transformative venture. Watch the Unicorn Hunters trailer here Watch the episode here NEW YORK, Dec. 19, 2023
Recipharm Harmonizes its Global Quality Operations with Veeva Vault Quality
Leading CDMO adopts Veeva Vault QMS, Vault QualityDocs, and Vault Training to standardize quality processes and manage GxP content across its organization BARCELONA, Spain, Dec. 19, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Recipharm, a global contract development
